BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 33914202)

  • 1. Clinical features and risk factors of Raynaud's phenomenon in primary Sjögren's syndrome.
    Lin W; Xin Z; Ning X; Li Y; Ren X; Su Y; Liu M; Guo S; Yang L; Liu Y; Zhang F; Zhang W
    Clin Rheumatol; 2021 Oct; 40(10):4081-4087. PubMed ID: 33914202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticentromere antibody positive patients with primary Sjögren's syndrome have distinctive clinical and immunological characteristics.
    Liu Y; Guo L; Lin W; Ning X; Liu M; Cao J; Su Y; Zheng X; Li S; Li F; Ren L; Song G
    Clin Exp Rheumatol; 2023 Dec; 41(12):2371-2378. PubMed ID: 36995331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raynaud's phenomenon in primary Sjögren's syndrome. Prevalence and clinical characteristics in a series of 320 patients.
    García-Carrasco M; Sisó A; Ramos-Casals M; Rosas J; de la Red G; Gil V; Lasterra S; Cervera R; Font J; Ingelmo M
    J Rheumatol; 2002 Apr; 29(4):726-30. PubMed ID: 11950013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.
    Corominas H; Ortiz-Santamaría V; Castellví I; Moreno M; Morlà R; Clavaguera T; Erra A; Martínez-Pardo S; Ordóñez S; Santo P; Reyner P; González MJ; Codina O; Gelman MS; Juanola-Roura X; Olivé A; Torrente-Segarra V;
    Rheumatol Int; 2016 Mar; 36(3):365-9. PubMed ID: 26597492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma is increased in patients with primary Sjogren's syndrome and Raynaud's phenomenon.
    Willeke P; Schlüter B; Schotte H; Domschke W; Gaubitz M; Becker H
    Semin Arthritis Rheum; 2009 Dec; 39(3):197-202. PubMed ID: 18571695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raynaud's phenomenon in primary Sjögren's syndrome.
    Skopouli FN; Talal A; Galanopoulou V; Tsampoulas CG; Drosos AA; Moutsopoulos HM
    J Rheumatol; 1990 May; 17(5):618-20. PubMed ID: 2359071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development.
    Goules AV; Argyropoulou OD; Pezoulas VC; Chatzis L; Critselis E; Gandolfo S; Ferro F; Binutti M; Donati V; Zandonella Callegher S; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos T; Mavragani CP; Baldini C; Skopouli FN; Fotiadis DI; De Vita S; Moutsopoulos HM; Tzioufas AG
    Front Immunol; 2020; 11():594096. PubMed ID: 33193443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raynaud's phenomenon in primary Sjögren's syndrome. Association with other extraglandular manifestations.
    Kraus A; Caballero-Uribe C; Jakez J; Villa AR; Alarcón-Segovia D
    J Rheumatol; 1992 Oct; 19(10):1572-4. PubMed ID: 1464870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for progression and prognosis of primary Sjögren's syndrome-associated interstitial lung disease in a Chinese population.
    Xu Y; Zhou J; Dong X; Guo X; Lu Y; Zheng Y
    Int J Rheum Dis; 2020 Dec; 23(12):1734-1740. PubMed ID: 33226736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinical analysis of primary Sjögren's syndrome with anticentromere antibodies].
    Yan SM; Zeng XF; Zhao Y; Dong Y
    Zhonghua Nei Ke Za Zhi; 2008 Apr; 47(4):296-9. PubMed ID: 18843953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum CXCL4 increase in primary Sjögren's syndrome characterizes patients with microvascular involvement and reduced salivary gland infiltration and lymph node involvement.
    Vettori S; Irace R; Riccardi A; Iacono D; Pellecchia L; Vicedomini L; Valentini G
    Clin Rheumatol; 2016 Oct; 35(10):2591-6. PubMed ID: 27562035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial lung disease in Primary Sjögren's syndrome.
    Lin W; Xin Z; Zhang J; Liu N; Ren X; Liu M; Su Y; Liu Y; Yang L; Guo S; Yang Y; Li Y; Cao J; Ning X; Li J; Xue H; Niu N; Chen Y; Li F; Sun L; Zhang X; Zhang F; Zhang W
    BMC Pulm Med; 2022 Feb; 22(1):73. PubMed ID: 35220958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical influences of anticentromere antibody on primary Sjögren's syndrome in a prospective Korean cohort.
    Park Y; Lee J; Koh JH; Choe JY; Sung YK; Lee SS; Kim JM; Park SH; Kwok SK
    Korean J Intern Med; 2021 Nov; 36(6):1492-1503. PubMed ID: 32829574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome.
    Salliot C; Gottenberg JE; Bengoufa D; Desmoulins F; Miceli-Richard C; Mariette X
    J Rheumatol; 2007 Nov; 34(11):2253-8. PubMed ID: 17937465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and risk factors of pulmonary arterial hypertension in patients with primary Sjögren's syndrome.
    Yan S; Li M; Wang H; Yang X; Zhao J; Wang Q; Liu Y; Lai J; Tian Z; Song H; Zhao Y; Zeng X
    Int J Rheum Dis; 2018 May; 21(5):1068-1075. PubMed ID: 29624870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial lung disease in primary Sjögren's syndrome.
    Roca F; Dominique S; Schmidt J; Smail A; Duhaut P; Lévesque H; Marie I
    Autoimmun Rev; 2017 Jan; 16(1):48-54. PubMed ID: 27682894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of clinical features and prognosis in patients with primary Sjögren's syndrome and autoimmune liver disease].
    Chen WQ; Dai XN; Yu Y; Wang Q; Liang JY; Ke YN; Yi CH; Lin J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):886-891. PubMed ID: 33047724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-RNP positivity in primary Sjögren's syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement.
    Abbara S; Seror R; Henry J; Chretien P; Gleizes A; Hacein-Bey-Abina S; Mariette X; Nocturne G
    RMD Open; 2019; 5(2):e001033. PubMed ID: 31673417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Raynaud's phenomenon be defined as a subtype of primary Sjögren's syndrome? Comments on "Clinical features and risk factors of Raynaud's phenomenon in primary Sjögren's syndrome".
    Chen C; Liang Y; Yang Z
    Clin Rheumatol; 2022 Apr; 41(4):1265-1266. PubMed ID: 35059878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.